Product Information
URSODIOL 300 MG CAPSULE is a generic product labeled by Actavis Pharma, Inc., priced at $0.4160 per EA under NDC 00591315901. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Dec 31, 1987. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
300 mg/1
Manufacturer
Actavis Pharma, Inc.NDC
00591315901
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
URSODIOLApproval Type
Authorized Generic (NDA)
FDA Application
NDA019594FDA Approved
12/31/1987
TE Code
AB
On Market Since
12/31/1987
Pharmacological Classes
Price Statistics
The NADAC for URSODIOL 300 MG CAPSULE has been published 665 times since Nov 28, 2013, and over the history we have for it it has risen 48.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4160 per EA |
|---|---|
| All-time high | $4.7335 (Oct 15, 2014) |
| All-time low | $0.2803 (Nov 28, 2013) |
| 52-week high | $0.4998 |
| 52-week low | $0.4160 |
| Median price | $0.6902 |
| Average price | $1.6279 |
| Largest weekly change | +195.1% (Jun 11, 2014) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 14 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of URSODIOL 300 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for URSODIOL 300 MG CAPSULE, manufactured by Actavis Pharma, Inc., is $0.4160 per EA (NDC 00591315901), effective Aug 19, 2026.
How has the price of URSODIOL 300 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for URSODIOL 300 MG CAPSULE has risen 48.4%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for URSODIOL 300 MG CAPSULE?
Since Nov 28, 2013, the NADAC for URSODIOL 300 MG CAPSULE has ranged from a low of $0.2803 (Nov 28, 2013) to a high of $4.7335 (Oct 15, 2014), with a median of $0.6902 per EA.
Are there cheaper alternatives to URSODIOL 300 MG CAPSULE?
14 manufacturers publish a NADAC-priced product with the same active ingredient and strength as URSODIOL 300 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures URSODIOL 300 MG CAPSULE?
URSODIOL 300 MG CAPSULE (NDC 00591315901) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.